Onkure therapeutics, inc.OKUR.US Overview

US StockHealthcare

(No presentation for OKUR)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

OKUR Overall Performance

OKUR AI Analysis & Strategy

OKUR Recent Performance

-3.87%

Onkure therapeutics, inc.

0.81%

Avg of Sector

-1.14%

S&P500

OKUR PowerScanner

OKUR Key Information

OKUR Valuation Metrics

OKUR Earnings Table

OKUR Profile

OnKure, Inc. engages in the discovery and development of oncology-precision medicines for the treatment of cancer. The company focuses on developing selective inhibitors of histone deacetylases. Its portfolio includes OKI-179, an inhibitor for the treatment of both hematological and solid tumors. The company was incorporated in 2011 and is based in Boulder, Colorado.